Latest filing published 07 Apr 2020 for PDL BIOPHARMA, INC., €264k.
Insider track record
No signal scores available.
Edward Imbrogno: trading record in brief
This profile gathers the share dealings of Edward Imbrogno in PDL Biopharma, Inc. In total, 3 filings cover trades dated from 8 January 2020 to 7 February 2020.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
The latest filing, published on 7 April 2020, reports a share grant of €264k in PDL Biopharma, Inc. Typically, a trade is published a median of 60 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Edward Imbrogno
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 82,488 shares@ US$3.51100.0% of flowCommon stockSEC:0000882104-20-000043:0
- 292,208 shares0Common stockSEC:0000882104-20-000047:0
- 292,208 shares0Common stockSEC:0000882104-20-000008:0
3 of 3 declarations
